The signal transduction pathways responsible for the inhibitory effects of CD200R1 engagement have only been partially described in mouse mast cells overexpressing CD200R1 differentiated in vitro[29] and in the human lymphoma cell line U937 [30]. Here, CD200R1 is linked to lymphoma.